Companion Diagnostic Development: Current trends and recommendations

Examining the trends in personalized medicine sheds light on ways to create successful partnerships between sponsors, laboratories, and manufacturers of in-vitro diagnostic products (IVDs) to develop more efficiently stand-alone diagnostics, companion diagnostics (CDx), and complementary diagnostics. This is particularly relevant in light of the paradigm shift on the horizon for developing and ensuring reimbursement of such personalized medicine solutions with new technologies. Download this insight brief now to learn six strategies for success when developing your companion diagnostic.

Patrice Hugo, PhD, Chief Scientific Officer
Richard Heichemer, MS, MBA, Scientific Advisor, Companion Diagnostics

Complete the form below to access this insight brief